Manifestaciones cutáneas en adultos con trasplante hepático del Hospital Clínico de la Universidad de Chile
Author
dc.contributor.author
Daza, Francisca
Author
dc.contributor.author
Poniachik Teller, Jaime
Author
dc.contributor.author
Zemelman Decarli, Viviana
Author
dc.contributor.author
Ibarra, José
Author
dc.contributor.author
Espinoza, Miguel
Author
dc.contributor.author
Castillo Koch, Jaime
Author
dc.contributor.author
Cardemil Herrera, Gonzalo
Author
dc.contributor.author
Díaz Jeraldo, Juan
Author
dc.contributor.author
Saure Maritano, Alexandre
Author
dc.contributor.author
Lembach Jahnsen, Hanns
Author
dc.contributor.author
Calderón Herschman, Perla
Admission date
dc.date.accessioned
2015-09-14T15:54:31Z
Available date
dc.date.available
2015-09-14T15:54:31Z
Publication date
dc.date.issued
2015
Cita de ítem
dc.identifier.citation
Revista médica de Chile. Volumen: 143 Número: 5 Páginas: 584-588
en_US
Identifier
dc.identifier.other
DOI: 10.4067/S0034-98872015000500005
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/133622
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Background: Skin manifestations after liver transplantation are increasing due to long term immunosuppressive therapy along with an increase in patient survival. Several studies have reported dermatologic complications following renal transplant, but few have studied dermatologic problems after liver transplantation. Aims: To describe the different types of cutaneous lesions encountered in adults receiving a liver allograft. To evaluate the frequency of cutaneous manifestations of patients in the liver transplant waiting list. Material and Methods: Eighty patients submitted to a liver transplant and 70 patients in the liver transplant waiting list were evaluated with a complete dermatological physical examination. Results: Sixty one percent of patients with a liver allograft had at least one skin manifestation. Of these, 34% had superficial fungal infections, 31% had viral infections, 20% had cutaneous side effects due to immunosuppressive treatment, 10% had malignant lesions, 2% had bacterial infections and one patient had a graft versus host disease. Only 28% of patients in the liver transplant waiting list had dermatologic problems, and the vast majority were lesions linked to liver cirrhosis. Conclusions: Cutaneous infections were the most common skin problems in liver transplant patients. Although neoplastic lesions are the most commonly mentioned lesions in the literature, only a 10% of our liver transplant patients presented these type of lesions.